Tumor
168
33
42
71
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
15 trials with published results (9%)
Research Maturity
71 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.0%
10 terminated out of 168 trials
87.7%
+1.1% vs benchmark
5%
9 trials in Phase 3/4
21%
15 of 71 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 71 completed trials
Clinical Trials (168)
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures
Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
FAPI PET/CT in Various FAP-Related Disease Patients
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT Trial
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology